Gomes Aldrin V, Harada Keita, Potter James D
Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, 1600 N.W. 10th Avenue, Miami, FL 33136, USA.
J Mol Cell Cardiol. 2005 Nov;39(5):754-65. doi: 10.1016/j.yjmcc.2005.05.013. Epub 2005 Jul 6.
The first human cardiac troponin I (hcTnI) mutation in the N-terminal 32 residue region, R21C (arginine residue number 21 mutated to cysteine), which has been linked to hypertrophic cardiomyopathy (HCM), has recently been reported. The effect of this mutation on the physiological function of hcTnI was investigated. Human cTnI R21C (in the absence or presence of troponin T and troponin C) was phosphorylated by protein kinase A (PKA) at a significantly slower rate than wild-type hcTnI. In skinned fiber studies, the TnI R21C mutant showed a large increase in Ca(2+)-sensitivity of force development when compared to wild-type TnI (DeltapCa(50)=0.33). Phosphorylation of skinned fibers containing TnI R21C by PKA resulted in a significantly smaller decrease in the Ca(2+)-sensitivity of force development when compared to phosphorylation of fibers containing wild-type TnI. The decreased sensitivity of TnI R21C to PKA is most likely due to a decreased ability of PKA to phosphorylate this TnI rather than conformational problems within this TnI. In addition, skinned fibers were found to contain an endogenous kinase that is capable of phosphorylating wild-type TnI. However, the endogenous kinase activity did not affect the Ca(2+)-sensitivity of force development, the Hill coefficient or maximal force of these skinned fibers. Actomyosin ATPase assays showed that the R21C mutation did not affect the inhibitory properties of TnI or the maximal ATPase activity. TnI R21C was also found to be more susceptible to proteolysis by calpain II than wild-type TnI. These results suggest that this R21C mutation in TnI affects the Ca(2+)-sensitizing effect of Tn, the ability of TnI to be readily phosphorylated by PKA and the stability of TnI to calpain. The results also suggest that the N-terminal region may have important roles such as modulating the Ca(2+)-sensitivity of force-development.
最近有报道称,在N端32个残基区域发现了首例人类心肌肌钙蛋白I(hcTnI)突变,即R21C(精氨酸残基第21位突变为半胱氨酸),该突变与肥厚型心肌病(HCM)有关。研究了此突变对hcTnI生理功能的影响。人cTnI R21C(在存在或不存在肌钙蛋白T和肌钙蛋白C的情况下)被蛋白激酶A(PKA)磷酸化的速率明显慢于野生型hcTnI。在对去表皮肌纤维的研究中,与野生型TnI相比,TnI R21C突变体在力产生的Ca(2+)敏感性方面有大幅增加(DeltapCa(50)=0.33)。与含有野生型TnI的肌纤维磷酸化相比,PKA对含有TnI R21C的去表皮肌纤维进行磷酸化导致力产生的Ca(2+)敏感性下降明显更小。TnI R21C对PKA敏感性降低很可能是由于PKA磷酸化该TnI的能力下降,而非该TnI内部的构象问题。此外,发现去表皮肌纤维含有一种能够磷酸化野生型TnI的内源性激酶。然而,内源性激酶活性并未影响这些去表皮肌纤维力产生的Ca(2+)敏感性、希尔系数或最大力。肌动球蛋白ATP酶分析表明,R21C突变不影响TnI的抑制特性或最大ATP酶活性。还发现TnI R21C比野生型TnI更易被钙蛋白酶II水解。这些结果表明,TnI中的这种R21C突变影响Tn的Ca(2+)致敏作用、TnI被PKA轻易磷酸化的能力以及TnI对钙蛋白酶的稳定性。结果还表明,N端区域可能具有重要作用,例如调节力产生的Ca(2+)敏感性。